140 results on '"Kieslich, Katharina"'
Search Results
2. Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria
3. Approaches in Defining Governance
4. Recommendations
5. Imagined Futures: Trust and Justice in Synthetic Biology Governance
6. Case Study: COVID-19 Vaccine Development
7. Governance and Public Participation
8. Governance and Participation in Policy Literature on Synthetic Biology
9. Introduction
10. Conclusion
11. Solidarity in Times of a Pandemic: Everyday Practices and Prioritization Decisions in Light of the Solidarity Concept
12. Rethinking value construction in biomedicine and healthcare
13. Synthetic Biology and the Question of Public Participation
14. Collaborative comparisons: A pragmatist approach towards designing large-scale, comparative qualitative research
15. Democratic research: Setting up a research commons for a qualitative, comparative, longitudinal interview study during the COVID-19 pandemic
16. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
17. Solidarität in Zeiten einer Pandemie: Alltagspraktiken und Priorisierungentscheidungen im Lichte des Solidaritätskonzeptes
18. The Alternative for Germany (AfD) and Health Policy: Normalization or Containment of Populist Radical Right Tendencies?
19. Solidarity in Health Research Regulation
20. Creating sustainable health care systems : Agreeing social (societal) priorities through public participation
21. How reforms hamper priority-setting in health care: an interview study with local decision-makers in London.
22. How reforms hamper priority-setting in health care: an interview study with local decision-makers in London
23. Solidarity during the COVID-19 pandemic: evidence from a nine-country interview study in Europe
24. Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria
25. COVID-19 and techno-solutionism: responsibilization without contextualization?
26. The complexities of integrating evidence-based preventative health into England's NHS: lessons learnt from the case of PrEP.
27. Social values and health priority setting in Germany
28. Normative positions towards COVID-19 contact-tracing apps : findings from a large-scale qualitative study in nine European countries
29. Democratic research: Setting up a research commons for a qualitative, comparative, longitudinal interview study during the COVID-19 pandemic
30. Cost effective but unaffordable: an emerging challenge for health systems
31. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force
32. Normative positions towards COVID-19 contact-tracing apps: findings from a large-scale qualitative study in nine European countries
33. Rethinking value construction in biomedicine and healthcare
34. Zur Rolle der Wissenschaft in Pandemien : Für eine interdisziplinäre, transregionale und solidarische Forschung.
35. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
36. Patient and public involvement in priority‐setting decisions in England's Transforming NHS: An interview study with Clinical Commissioning Groups in South London sustainability transformation partnerships
37. Paradigms in operation: explaining pharmaceutical benefit assessment outcomes in England and Germany
38. National Institute for Health and Care Excellence, social values and healthcare priority setting
39. Addressing vaccination hesitancy in Europe: a case study in state–society relations
40. Paradigms in operation: explaining pharmaceutical benefit assessment outcomes in England and Germany.
41. Challenges for the new Cancer Drugs Fund
42. Improving Equitable Access to Health Care Through Increasing Patient and Public Involvement in Prioritisation Decisions
43. Why was a judicial review required to allow the English National Health Service to commission pre-exposure prophylaxis for HIV?
44. Public participation in decision-making on the coverage of new antivirals for hepatitis C
45. Setting standards and monitoring quality in the NHS 1999–2013: a classic case of goal conflict
46. Drug appraisal issues must be resolved at policy level
47. Public participation in decision-making on the coverage of new antivirals for hepatitis C
48. Improving equitable access to health care through increasing patient and public involvement in prioritisation decisions
49. Introduction: priority setting, equitable access and public involvement in health care
50. Public involvement in health priority setting: future challenges for policy, research and society
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.